HomeBUSINESS
BUSINESS

Canalia Grabs GPs’ Attention in September: Anterio Ranking
(Nov.21.2017)

Japan’s first DPP-4/SGLT-2 inhibitor combo Canalia (teneligliptin + canagliflozin) left the strongest impression on GPs in September through a series of promotional channels, including drug reps, a monthly survey showed ...
(LOG IN FOR FULL STORY)

News Calendar